Chris Manfuso has over 20 years of experience in the health sector. As the National Director of Sales for Enovachem Pharmaceuticals Torrance, an outsourcing healthcare company based in California, Chris Manfuso guided the company in manufacturing novel products that meet different industries’ needs.
Among other things, Enovachem Pharmaceuticals specialize in male and female hormone replacement therapy. Hormone replacement therapy (HRT) is a treatment that helps men and women replenish or replace certain hormones that diminish as they grow older.
The replacement therapy differs in both men and women. In men, the HRT seeks to replace declining testosterone levels. Testosterone helps men build muscle bulk, have increased bone density, and have an efficient reproductive function. On the other hand, HRT is key to replenishing Estrogen and other hormones, relieving the signs and symptoms of menopause.
HRT is necessary for both men and women because it helps them combat osteoporosis, a medical condition in which the bones become fragile, weakened, and likely fractured. It is adviced that women start HRT immediately they begin experiencing symptoms associated with menopause.
Chris Manfuso 